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Abstract 
 
Most definitions describing concept of nanotechnology includes control, 
understanding, design, imaging, measuring and manipulating matter at dimensions 
between 1 and 100 nanometers. Nano-structure poses unique physical, chemical 
and biological properties exclusively due to its nanoscale dimensions, significantly 
different from the properties of bulk materials and single atoms or molecules. Gravity 
loses impact and importance, surface tension and Van der Waals constants has 
more importance in system of nano particles. Extremely small size enables nano 
particles to enter the human body through usual or unusual routes, pass through cell 
membranes, cross the blood-brain barrier and access new sites, interact with DNA or 
small proteins at different levels, in blood or within organs, tissues or cells. 
Nowadays nanotechnology is being used in a range of applications, with 
potential to be applied at any stage in food industry: production, processing, 
packaging, labelling, transporting, tracing, keeping the quality of food product and 
extend the product shelf-life.  
The use of nanotechnologies to solve medical problems can dramaticaly 
improve the quality of life. Nanomedicine has the potential to enable early detection, 
prevention and significantly improve diagnosis, treatment and follow-up of many 
diseases.  
Based on nano (bio) senzors, rapid and sensitive detection of pathogenic 
bacteria and trace levels of viruses in small sample volumes and lower costs than 
current in-use technologies are developed. Early detection enables accurate and 
prompt treatment. Likewise, sensors to detect biofilm formation by bacteria on 
surfaces are developing 
Over 70 products are under clinical trials, covering important diseases 
including cardiovascular, neurodegenerative, musculoskeletal and inflammatory 
(such as cancer, atherosclerosis, diabetes, eye diseasses, antimicrobial resistance, 
tissue engineering, Alzheimer disease, arthritis).  Nanomedicine delivered over 70 
products, including nano-delivery, pharmaceuticals, imaging, diagnostics and 
biomaterials. Researchers have developed "nano-sponges" that absorb toxins and 
remove them from the bloodstream, absorb free radicals, monitor the level of nitric 
oxide (which indicate inflammation, important to monitor inflammatory diseases) in 
the bloodstream. 
Nanomedicine is understood to be a key enabling instrument for targeted and 
regenerative medicine by delivering of drugs (increases efficiency and minimizes side 
effects), treatments, implantable devices, early diagnosis of cancers, accurate cancer 
imaging, cancer therapy and drug delivery. 
Multy drug resistant microorganisms present one of the most serious and 
increasing global, public health threat. This problem causes approximately 25,000 
deaths each year and over 1.5 billion expenses in healthcare and productivity losses 
in Europe. New strategies to combat MDR are urgently needed and nanomaterials 
are very promising approach. Metal nanomaterials (silver, gold, copper, titanium, 
zinc, magnesium, cadmium and alumina) possess unique antimicrobial activities. 
Silver ions showed strongest bactericidal effect.  
Regenerative medicine based on tissue engineering is currently a great 
exciting challenge for science and industry.  
Nanoparticles are also used to stimulate the body’s innate repair mechanisms, 
artificial activation and control of adult stem cells and to deliver vaccine, allowing a 
stronger immune response 
Nanomedicine provides important new tools to deal with the grand challenge 
of an ageing population. 
Future applications of nanomedicine will be based on the ability to build 
nanorobots. These nanorobots could be programmed to repair specific diseased cells 
(„genetic surgery“), functioning in a similar way to antibodies in our natural healing 
processes and elimination of bacterial infection. Intense research is going on to make 
changes in the DNA structure of human beings as it can bring about a way to cure 
gene-related diseases. 
Risks of nanotechnology are still unknown and unpredictable.  
Potential problem with is the lack of knowledge and understanding the impact these 
products will have on the nanoscale. Initial scientific studies showed negative effects 
on living organisms and a potential for serious threat to human health in connection 
with disposal of nanowaste and environmental contamination. Scientists are primarily 
concerned with toxicity, characterization and exposure pathways. 
Number of ethical and societal concerns raised, ranging from possible health 
risks of using or consuming nanoenabled products, intellectual property rights 
governing them, and the new challenges they may raise. 
There are concerns that strong economic competition may be taking 
precedence over scientific prudence when it comes to public health and the potential 
dangers of nanotechnology. 
However, currently the benefits of nanomedicine definitely outweigh the risks.  
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